Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 8Seizures 6Glioma 3Glioblastoma 2Central Nervous System Neoplasms 2beta-Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasm, Residual 1Necrosis 1Meningioma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Influenza, Human 1Hematologic Neoplasms 1Gliosarcoma 1Epilepsy 1Ependymoma 1Chromosome Aberrations 1Chromosome 7, monosomy 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Levetiracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Necrosis × Levetiracetam × CNS × Clear all
NCT07130786 2026-03-19

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Brigham and Women's Hospital

Phase 2 Recruiting
150 enrolled
CNS

Brain Neoplasms, Necrosis, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡